BioMark Diagnostics Inc. reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was CAD 0.019818 million. Net loss was CAD 0.276697 million compared to CAD 0.194189 million a year ago.
For the nine months, sales was CAD 0.019818 million. Net loss was CAD 0.724031 million compared to CAD 0.510213 million a year ago.